Literature DB >> 18678987

Regulation of purinergic signaling by prostaglandin E2 in murine macrophages.

Masaaki Ito1, Isao Matsuoka.   

Abstract

Extracellular nucleotides are primary signals for tissue injury, acting together with various chemical mediators such as prostanoids at the inflammatory site. We investigated whether prostaglandin E2 (PGE2) affects purinergic signaling in murine J774 macrophages. J774 cells expressed four different purinoceptor mRNAs: the ionotropic P2X4 and P2X7 receptors and G-protein-coupled P2Y2 and P2Y6 receptors. Functional responses mediated by these purinoceptor subtypes were confirmed by measurement of intracellular Ca2+ concentration ([Ca2+]i) in fura-2-loaded cells. Thus, low concentrations (10 microM) of ATP (P2Y2 agonist) and UDP (P2Y6 agonist) evoked Ca2+ transient in a phospholipase C (PLC)-dependent manner, whereas the P2X7 agonist benzoylbenzoyl-ATP (BzATP, 500 microM) caused a sustained rise in [Ca2+]i. Furthermore, ivermectin, an activator of the P2X4-receptor channel, enhanced the ATP-induced [Ca2+]i elevation. PGE2 inhibited ATP- and UDP-induced [Ca2+]i elevation, without affecting the BzATP-induced sustained [Ca2+]i elevation. Stimulation of J774 cells by UDP or BzATP increased the production of macrophage inflammatory peptide-alpha (MIP-alpha). PGE2 abolished the UDP-induced MIP-alpha production, but not the BzATP-induced one. These results demonstrate that purinergic signalings in macrophages were regulated by PGE2 in a subtype-specific manner. The different inhibitory effects on distinct purinoceptor functions may be related to the anti-inflammatory property of PGE2.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678987     DOI: 10.1254/jphs.08087fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  5 in total

1.  Ivermectin-dependent release of IL-1beta in response to ATP by peritoneal macrophages from P2X(7)-KO mice.

Authors:  Michèle Seil; Malika El Ouaaliti; Unai Fontanils; Irantzu Gorrono Etxebarria; Stéphanie Pochet; Giulia Dal Moro; Aida Marino; Jean-Paul Dehaye
Journal:  Purinergic Signal       Date:  2010-11-20       Impact factor: 3.765

2.  The therapeutic potential of adenosine triphosphate as an immune modulator in the treatment of HIV/AIDS: a combination approach with HAART.

Authors:  Marc C E Wagner
Journal:  Curr HIV Res       Date:  2011-06       Impact factor: 1.581

3.  Prostaglandin E2 Impairs P2Y2/P2Y4 Receptor Signaling in Cerebellar Astrocytes via EP3 Receptors.

Authors:  Lucía Paniagua-Herranz; Juan C Gil-Redondo; Ma José Queipo; Silvia González-Ramos; Lisardo Boscá; Raquel Pérez-Sen; Ma Teresa Miras-Portugal; Esmerilda G Delicado
Journal:  Front Pharmacol       Date:  2017-12-22       Impact factor: 5.810

4.  Glibenclamide decreases ATP-induced intracellular calcium transient elevation via inhibiting reactive oxygen species and mitochondrial activity in macrophages.

Authors:  Duo-ling Li; Zhi-yong Ma; Zhi-jie Fu; Ming-ying Ling; Chuan-zhu Yan; Yun Zhang
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

5.  Sustained release of prostaglandin E₂ in fibroblasts expressing ectopically cyclooxygenase 2 impairs P2Y-dependent Ca²⁺-mobilization.

Authors:  María Pimentel-Santillana; Paqui G Través; Raquel Pérez-Sen; Esmerilda G Delicado; Paloma Martín-Sanz; María Teresa Miras-Portugal; Lisardo Boscá
Journal:  Mediators Inflamm       Date:  2014-08-18       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.